We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $118M
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$297M
AUM Growth
+$56.9M
Cap. Flow
+$55.4M
Cap. Flow %
18.67%
Top 10 Hldgs %
80.3%
Holding
232
New
27
Increased
80
Reduced
67
Closed
26

Sector Composition

Rank Sector Weight
1 Real Estate 18.29%
2 Healthcare 13.15%
3 Technology 2%
4 Industrials 1.37%
5 Consumer Discretionary 1.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWM icon
151
iShares MSCI Malaysia ETF
EWM
$305M
$104K 0.04%
3,851
+456
+13% +$12.7K
EPOL icon
152
iShares MSCI Poland ETF
EPOL
$669M
$102K 0.03%
5,611
+232
+4% +$4.42K
DBTX
153
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$102K 0.03%
+9,000
New +$141K
EPHE icon
154
iShares MSCI Philippines ETF
EPHE
$127M
$101K 0.03%
3,470
+412
+13% +$12.8K
EIDO icon
155
iShares MSCI Indonesia ETF
EIDO
$476M
$100K 0.03%
4,584
+258
+6% +$6.06K
FXI icon
156
iShares China Large-Cap ETF
FXI
$4.31B
$100K 0.03%
2,135
+132
+7% +$6.55K
HYD icon
157
VanEck High Yield Muni ETF
HYD
$4.44B
$100K 0.03%
1,608
+1,258
+359% +$78.1K
EPU icon
158
iShares MSCI Peru and Global Exposure ETF
EPU
$534M
$96K 0.03%
2,826
+8
+0.3% +$289
IOVA icon
159
Iovance Biotherapeutics
IOVA
$2.23B
$95K 0.03%
3,000
+1,000
+50% +$41.5K
CNST
160
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$94K 0.03%
4,000
HYMB icon
161
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.07B
$92K 0.03%
3,090
+2,350
+318% +$69.8K
UTHR icon
162
United Therapeutics
UTHR
$26.3B
$92K 0.03%
550
-200
-27% -$33.3K
HZNP
163
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$92K 0.03%
1,000
STRO icon
164
Sutro Biopharma
STRO
$379M
$91K 0.03%
400
BIO icon
165
Bio-Rad Laboratories Class A
BIO
$8.42B
$90K 0.03%
157
-3
-2% -$1.78K
FLRN icon
166
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.11B
$89K 0.03%
2,905
+291
+11% +$8.92K
IGSB icon
167
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
$89K 0.03%
1,623
+172
+12% +$9.45K
MUB icon
168
iShares National Muni Bond ETF
MUB
$45.1B
$89K 0.03%
770
+85
+12% +$9.91K
SCHP icon
169
Schwab US TIPS ETF
SCHP
$16.3B
$89K 0.03%
2,906
+306
+12% +$9.43K
ALXN
170
DELISTED
Alexion Pharmaceuticals
ALXN
$89K 0.03%
580
WIP icon
171
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$479M
$87K 0.03%
1,568
+156
+11% +$8.94K
APLS
172
DELISTED
Apellis Pharmaceuticals
APLS
$86K 0.03%
2,000
TUR icon
173
iShares MSCI Turkey ETF
TUR
$206M
$82K 0.03%
3,547
-676
-16% -$18.6K
NMCO icon
174
Nuveen Municipal Credit Opportunities Fund
NMCO
$579M
$75K 0.03%
5,367
+3,500
+187% +$48.6K
NMZ icon
175
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.2B
$75K 0.03%
+5,202
New +$74.7K

Similar funds

AlphaCentric Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, AlphaCentric Advisors held 232 positions worth $297M, up 24% from $240M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

AlphaCentric Advisors deployed $55.4M of net new capital in Q1 2021, opening 27 new positions and adding to 80 existing holdings. Its largest new stake was Luminar Technologies: 3,333 shares worth $1.22M.

By sector, the portfolio is most concentrated in Real Estate at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Omnicell, an estimated $641K trimmed.

  • AlphaCentric Advisors's largest Q1 2021 buy was Luminar Technologies: 3,333 shares worth $1.22M.
  • AlphaCentric Advisors added most to iShares MBS ETF in Q1 2021, an estimated $25.2M increase.
  • AlphaCentric Advisors's biggest Q1 2021 reduction was Omnicell, cutting an estimated $641K.
  • AlphaCentric Advisors fully exited Globus Medical in Q1 2021, selling an estimated $978K.
  • AlphaCentric Advisors's ten largest holdings make up 80% of its $297M portfolio in Q1 2021.
  • AlphaCentric Advisors opened 27 new positions and closed 26 in Q1 2021.
  • AlphaCentric Advisors's portfolio value rose 24% quarter-over-quarter to $297M.

Based on AlphaCentric Advisors's 13F filing for Q1 2021, filed 9 Mar 2022.